Advances in Therapy for Psoriasis: An Overview of Infliximab, Etanercept, Efalizumab, Alefacept, Adalimumab, Tazarotene, and Pimecrolimus

Ritu Saini(Unknown), Jeffrey Weinberg(Columbia University), William D Tutrone
Current Pharmaceutical Design
January 1, 2005
Cited by 40


Related Papers